Pure Global

FEBRILE S. TYPHI O ANTIGEN(SEROCON FEBRILE S. TYPHI O ANTIGEN ) - India CDSCO Medical Device Registration

FEBRILE S. TYPHI O ANTIGEN(SEROCON FEBRILE S. TYPHI O ANTIGEN ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000017_f7e5e5cdcfe40dff301cd7c96989696d_63a4f3784bdbcf46390e7d3df350dd3b. This device is marketed under the brand name SEROCON CYSTATIN C CONTROL SET. The license holder is Beacon Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Gujarat.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
FEBRILE S. TYPHI O ANTIGEN(SEROCON FEBRILE S. TYPHI O ANTIGEN )
UID: MFG/MD/2020/000017_f7e5e5cdcfe40dff301cd7c96989696d_63a4f3784bdbcf46390e7d3df350dd3b

Brand Name

SEROCON CYSTATIN C CONTROL SET

Device Class

Class B

Approving Authority

Gujarat

Product Information

For detection of specific antibodies present in response to the stimulation by specific antigen of salmonella (SEROCON CYSTATIN C CONTROL SET)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing